• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

NVAX:US

5.9700 USD 0.0500 0.84%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Novavax Inc (NVAX)

Open: 5.9100 Day's Range: 5.8300 - 6.0800 Volume: 5,875,278
Previous Close: 5.9200 52wk Range: 3.3400 - 6.9500 1-Yr Rtn: +27.56%

Stock Chart for NVAX

No chart data available.
  • NVAX:US 5.9750
  • 1D
  • 1M
  • 1Y
5.9200
Interactive NVAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NVAX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3019
Est. EPS (USD) (12/2014) -0.3150
Est. PEG Ratio -
Market Cap (M USD) 1,423.71
Shares Outstanding (M) 238.48
30 Day Average Volume 3,130,526
Price/Book (mrq) 5.4408
Price/Sale (ttm) 39.7570
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NVAX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NVAX

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Stanley C ErckPresident/CEOBarclay A Phillips "Buck"Senior VP/CFO/Treasurer
Russell P Wilson "Rip"Senior VP:Business DevelopmentJohn J TrizzinoSenior VP:Commercial Operations
More Company Profile & Key Executives for NVAX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil